MSB 7.69% $1.19 mesoblast limited

CHF - MSB's Dark Horse with Multi-billion dollar potential, page-147

  1. 1,787 Posts.
    lightbulb Created with Sketch. 484
    Patents don't make money. Revenue, profits and cash flow are inputs to derive a valuation, not patents.

    MSB has consistently been one of the worst possible investments on the ASX over a very long period of time on just about any metric you want to measure. Always showing glimmers of hope, but never much in the way of results.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.